Assessing the impact of HL7/FDA Structured Product Label (SPL) content for medication knowledge management.
The amount and quality of the SPL drug knowledge which has been released so far is assessed. All published labels were loaded into a relational database and classified to create vendor-independent descriptions. While SPL labels cover only 23% of RxNorm clinical drugs, they still describe 78% of actual community pharmacy dispenses records. SPL descriptions agree well with RxNorm. SPL can be used as the primary source of drug information for e-prescribing systems once the upcoming FDA listing rule takes effect. In the interim, existing gaps can be temporarily closed with RxNorm or other sources.
Schadow
Gunther
G
Regenstrief Institute, Indiana University School of Informatics, Indianapolis, IN, USA.
D004348:Drug Labeling / Q000331:legislation & jurisprudence; D033161:Government Regulation; D006801:Humans; D019451:Information Management; D020407:Internet; D050316:Medical Order Entry Systems; D004364:Pharmaceutical Preparations / Q000145:classification*; D014481:United States; D014486:United States Food and Drug Administration
D004364:Pharmaceutical Preparations